LIXT icon

Lixte Biotechnology

11 hedge funds and large institutions have $4.43M invested in Lixte Biotechnology in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
AIP
1
Almanack Investment Partners
Pennsylvania
$2.98M 982,046 -60,059 -6%
SMP
2
Santa Monica Partners
Florida
$505K 166,667
Vanguard Group
3
Vanguard Group
Pennsylvania
$225K 74,383 +74,383 New
Morgan Stanley
4
Morgan Stanley
New York
$215K 71,054 +50,001 +238%
SM
5
Sabby Management
Florida
$199K 65,511 -14,224 -18%
Renaissance Technologies
6
Renaissance Technologies
New York
$154K 50,900 +50,900 New
State Street
7
State Street
Massachusetts
$102K 33,600 +33,600 New
Citadel Advisors
8
Citadel Advisors
Florida
$38K 12,394 -11,419 -48%
BlackRock
9
BlackRock
New York
$14K 4,599 +4,296 +1,418%
UBS Group
10
UBS Group
Switzerland
$6K 1,905 +1,905 New
TRCT
11
Tower Research Capital (TRC)
New York
-1,574 Closed
Wells Fargo
12
Wells Fargo
California
$0 16
CFGS
13
Concourse Financial Group Securities
Alabama